Thorsten J. Maier

2.5k total citations
43 papers, 1.9k citations indexed

About

Thorsten J. Maier is a scholar working on Molecular Biology, Pharmacology and Genetics. According to data from OpenAlex, Thorsten J. Maier has authored 43 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Pharmacology and 7 papers in Genetics. Recurrent topics in Thorsten J. Maier's work include Inflammatory mediators and NSAID effects (12 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and COVID-19 Clinical Research Studies (6 papers). Thorsten J. Maier is often cited by papers focused on Inflammatory mediators and NSAID effects (12 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and COVID-19 Clinical Research Studies (6 papers). Thorsten J. Maier collaborates with scholars based in Germany, Denmark and Italy. Thorsten J. Maier's co-authors include Gerd Geißlinger, Sabine Grösch, Andreas Schieber, Reinhold Carle, Dietmar R. Kammerer, Susanne Schiffmann, Ronald Schmidt, Dieter Steinhilber, Carlo Angioni and Jessica Roos and has published in prestigious journals such as Journal of Clinical Investigation, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Thorsten J. Maier

43 papers receiving 1.8k citations

Peers

Thorsten J. Maier
Juan Mestre United States
Eun Kyung Yang United States
Francesco Giuliano United Kingdom
Paula B. Luis United States
Syng‐Ook Lee South Korea
David J. Boocock United Kingdom
Juan Mestre United States
Thorsten J. Maier
Citations per year, relative to Thorsten J. Maier Thorsten J. Maier (= 1×) peers Juan Mestre

Countries citing papers authored by Thorsten J. Maier

Since Specialization
Citations

This map shows the geographic impact of Thorsten J. Maier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thorsten J. Maier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thorsten J. Maier more than expected).

Fields of papers citing papers by Thorsten J. Maier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thorsten J. Maier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thorsten J. Maier. The network helps show where Thorsten J. Maier may publish in the future.

Co-authorship network of co-authors of Thorsten J. Maier

This figure shows the co-authorship network connecting the top 25 collaborators of Thorsten J. Maier. A scholar is included among the top collaborators of Thorsten J. Maier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thorsten J. Maier. Thorsten J. Maier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hein, Sascha, et al.. (2023). The fourth vaccination with a non-SARS-CoV-2 variant adapted vaccine fails to increase the breadth of the humoral immune response. Scientific Reports. 13(1). 10820–10820. 4 indexed citations
4.
Hein, Sascha, Christine von Rhein, Doris Oberle, et al.. (2022). The SARS-CoV-2 Variant Omicron Is Able to Escape Vaccine-Induced Humoral Immune Responses, but Is Counteracted by Booster Vaccination. Vaccines. 10(5). 794–794. 6 indexed citations
6.
Kahnt, Astrid S., Carlo Angioni, Bettina Hofmann, et al.. (2022). Inhibitors of Human 5-Lipoxygenase Potently Interfere With Prostaglandin Transport. Frontiers in Pharmacology. 12. 782584–782584. 16 indexed citations
7.
Maier, Thorsten J., et al.. (2021). Quantitative assays reveal cell fusion at minimal levels of SARS-CoV-2 spike protein and fusion from without. iScience. 24(3). 102170–102170. 29 indexed citations
8.
Brand, Silke, Peter Schröder, Jessica Roos, et al.. (2018). Combined Proteomic and In Silico Target Identification Reveal a Role for 5-Lipoxygenase in Developmental Signaling Pathways. Cell chemical biology. 25(9). 1095–1106.e23. 14 indexed citations
9.
Fischer, Dania, Patrick C. Baer, Michaela Jung, et al.. (2018). The Fibrin Cleavage Product Bβ15-42 Channels Endothelial and Tubular Regeneration in the Post-acute Course During Murine Renal Ischemia Reperfusion Injury. Frontiers in Pharmacology. 9. 369–369. 3 indexed citations
10.
Pace, Simona, Carlo Pergola, Friederike Dehm, et al.. (2017). Androgen-mediated sex bias impairs efficiency of leukotriene biosynthesis inhibitors in males. Journal of Clinical Investigation. 127(8). 3167–3176. 76 indexed citations
11.
Ahmad, Khalil Ali, Jessica Roos, Tomohiro Chiba, et al.. (2015). 5-Lipoxygenase is a direct p53 target gene in humans. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1849(8). 1003–1016. 29 indexed citations
12.
Roos, Jessica, Astrid S. Kahnt, Ewgenij Proschak, et al.. (2014). 5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell–like Cells in Acute Myeloid Leukemia. Cancer Research. 74(18). 5244–5255. 42 indexed citations
13.
Kahnt, Astrid S., Bettina Hofmann, Carlo Angioni, et al.. (2013). Cysteinyl leukotriene-receptor-1 antagonists interfere with PGE2 synthesis by inhibiting mPGES-1 activity. Biochemical Pharmacology. 86(2). 286–296. 24 indexed citations
14.
Dovizio, Melania, Stefania Tacconelli, Emanuela Ricciotti, et al.. (2012). Effects of Celecoxib on Prostanoid Biosynthesis and Circulating Angiogenesis Proteins in Familial Adenomatous Polyposis. Journal of Pharmacology and Experimental Therapeutics. 341(1). 242–250. 28 indexed citations
15.
Steinhilber, Dieter, et al.. (2010). 5-Lipoxygenase: Underappreciated Role of a Pro-Inflammatory Enzyme in Tumorigenesis. Frontiers in Pharmacology. 1. 143–143. 46 indexed citations
16.
Pergola, Carlo, Sven George, Julia Metzner, et al.. (2009). Sulindac sulfide suppresses 5-lipoxygenase at clinically relevant concentrations. Cellular and Molecular Life Sciences. 67(5). 797–806. 20 indexed citations
17.
Schiffmann, Susanne, Thorsten J. Maier, Ivonne Wobst, et al.. (2008). The anti-proliferative potency of celecoxib is not a class effect of coxibs. Biochemical Pharmacology. 76(2). 179–187. 48 indexed citations
18.
Grösch, Sabine, Thorsten J. Maier, Susanne Schiffmann, & Gerd Geißlinger. (2006). Cyclooxygenase-2 (COX-2)–Independent Anticarcinogenic Effects of Selective COX-2 Inhibitors. JNCI Journal of the National Cancer Institute. 98(11). 736–747. 381 indexed citations
19.
Maier, Thorsten J., Dietmar R. Kammerer, Nicolai Berardini, et al.. (2006). Isolation of hydroxycinnamoyltartaric acids from grape pomace by high-speed counter-current chromatography. Journal of Chromatography A. 1128(1-2). 61–67. 28 indexed citations
20.
Maier, Thorsten J., et al.. (2004). Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells. Biochemical Pharmacology. 67(8). 1469–1478. 154 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026